First Opinion By Julie L. Gerberding Antibiotic resistance: the hidden threat lurking behind Covid-19
Health By Helen Branswell Antibiotics could dramatically reduce STIs, study says, raising tough new questions
Health By Catherine Caruso Flesh-eating bacteria: 5 things to know after a hiker’s almost-fatal infection
Health By Helen Branswell Scarlet fever, a disease of yore, is making a comeback in parts of the world
Health By Helen Branswell Patients with feared superbug shed large amounts of it from their skin, study says
First Opinion By Jowa (Zhuo) Shi and Ateev Mehrotra Inappropriately prescribed antibiotics will likely accompany the winter surge of Covid-19
Pharma By Ed Silverman New bill would create a subscription payment model to jumpstart antibiotic development
Pharmalot By Ed Silverman Doctors say antibiotic resistance is an issue — but most say they’re not part of the problem
First Opinion By Kevin Outterson and John Rex We need new antimicrobials to prevent the next infectious disease crisis
Special Report By Gardiner Harris and Alex W. Palmer — The Wire China has near-total control of the world’s antibiotic supply. Is America at risk as a result?
First Opinion By Isaac Stoner Saving lives should be good business. Why doesn’t that apply to finding new antibiotics?
Pharmalot By Ed Silverman WHO adviser says an antimicrobial fund can help a market that ‘needs to be fixed’
Pharmalot By Ed Silverman Pharmalittle: France indicts Sanofi over epilepsy drug risks; Trump talk of drug pricing in SOTU speech may backfire
First Opinion By Alba Tiley and Steve Brooks Companies must responsibly manufacture the antimicrobials society needs
Pharmalot By Ed Silverman Amid fears of superbugs, sales of antibiotics used in food-producing livestock rose last year
First Opinion By Alex M. Azar II and Robert R. Redfield U.S. continues to lead the fight against antibiotic resistance
Health By Helen Branswell CDC report: 35,000 Americans die of antibiotic-resistant infections each year
First Opinion By Seema Verma Seema Verma: CMS’s ‘expanded pathway’ for new antibiotics can help fight antimicrobial resistance
Pharmalot By Ed Silverman Pharmalittle: Biogen resurrects an Alzheimer’s drug; last-minute settlement in a big opioid trial
Pharmalot By Ed Silverman The use of antibiotics in food-producing livestock continues to drop in most of Europe
First Opinion By Manos Perros Wanted: better policies and incentives to revitalize R&D for new antimicrobial drugs
Pharmalot By Ed Silverman Pharmalittle: Opioid judge refuses to disqualify himself; Biocon to lower insulin price in some countries
Pharmalot By Ed Silverman Pharmalittle: Pelosi plan rests with Dems who get big pharma bucks; Novartis recalls heartburn meds from U.S.
Pharmalot By Ed Silverman Antibiotic resistance in food-producing animals surges in low- and middle-income countries
Biotech By Kate Sheridan The next frontier for the microbiome: vaginal fluid transplants that take aim at a common condition
Pharmalot By Ed Silverman Pharmalittle: Two drug makers may settle opioid case; FDA hands Sarepta a surprising setback
In the Lab By Helen Branswell Everyone agrees this superbug is a threat. Few are willing to fund research to stop it
Health By Meghana Keshavan Fixing a ‘market failure’: To develop new antibiotics, upend the incentive structure, experts urge
First Opinion By Kevin Outterson and Helen W. Boucher Medicare payment rules hinder the fight against superbugs